Indexed keywords
ACTIVATING TRANSCRIPTION FACTOR;
ACTIVATING TRANSCRIPTION FACTOR 5;
BMI1 PROTEIN;
HOMEODOMAIN PROTEIN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
NOTCH RECEPTOR;
POLYCOMB GROUP PROTEIN;
STAT PROTEIN;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR AP 1;
TRANSCRIPTION FACTOR EZH2;
UNCLASSIFIED DRUG;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CARCINOGENESIS;
CELL AGING;
GLIOBLASTOMA;
LETTER;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
PROTEIN TARGETING;
SIGNAL TRANSDUCTION;
TRANSCRIPTION REGULATION;
ANTINEOPLASTIC AGENTS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
NEOPLASMS;
TRANSCRIPTION FACTORS;
1
67649365635
Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors
Karamouzis M.V., et al. Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors. Lancet Oncol. 2009, 10:709-717.
(2009)
Lancet Oncol. , vol.10
, pp. 709-717
Karamouzis, M.V.1
2
33645734522
Targeting transcription factors for cancer gene therapy
Libermann T.A., Zerbini L.F. Targeting transcription factors for cancer gene therapy. Curr. Gene Ther. 2006, 6:17-33.
(2006)
Curr. Gene Ther. , vol.6
, pp. 17-33
Libermann, T.A.1
Zerbini, L.F.2
3
74049084107
Defining and targeting transcription factors in cancer
Redmond A.M., Carroll J.S. Defining and targeting transcription factors in cancer. Genome Biol. 2009, 10:311.
(2009)
Genome Biol. , vol.10
, pp. 311
Redmond, A.M.1
Carroll, J.S.2
4
50249186849
Inhibition of transcription factors with small organic molecules
Berg T. Inhibition of transcription factors with small organic molecules. Curr. Opin. Chem. Biol. 2008, 12:464-471.
(2008)
Curr. Opin. Chem. Biol. , vol.12
, pp. 464-471
Berg, T.1
5
78649810959
Small-molecule regulators that mimic transcription factors
Rodríguez-Martínez J.A., et al. Small-molecule regulators that mimic transcription factors. Biochim. Biophys. Acta 2010, 1799:768-774.
(2010)
Biochim. Biophys. Acta , vol.1799
, pp. 768-774
Rodríguez-Martínez, J.A.1
6
77957931294
Translating DNA damage into cancer cell death - a roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance
Engelmann D., Pützer B.M. Translating DNA damage into cancer cell death - a roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance. Drug Resist. Updat. 2010, 13:119-131.
(2010)
Drug Resist. Updat. , vol.13
, pp. 119-131
Engelmann, D.1
Pützer, B.M.2
7
70449671729
Direct inhibition of the NOTCH transcription factor complex
(Erratum (2010) Nature 463, 384)
Moellering R.E., et al. Direct inhibition of the NOTCH transcription factor complex. Nature 2009, 462:182-188. (Erratum (2010) Nature 463, 384).
(2009)
Nature , vol.462
, pp. 182-188
Moellering, R.E.1
8
64849111865
Targeting STAT3 in cancer: how successful are we?
Yue P., Turkson J. Targeting STAT3 in cancer: how successful are we?. Expert Opin. Investig. Drugs 2009, 18:45-56.
(2009)
Expert Opin. Investig. Drugs , vol.18
, pp. 45-56
Yue, P.1
Turkson, J.2
9
57249111805
The transcription factor ATF5: role in neurodevelopment and neural tumors
Greene L.A., et al. The transcription factor ATF5: role in neurodevelopment and neural tumors. J. Neurochem. 2009, 108:11-22.
(2009)
J. Neurochem. , vol.108
, pp. 11-22
Greene, L.A.1
10
77951151837
Targeting HOX and PBX transcription factors in ovarian cancer
Morgan R., et al. Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer 2010, 10:89.
(2010)
BMC Cancer , vol.10
, pp. 89
Morgan, R.1
